Calcium-mediated histone modifications regulate alternative splicing in cardiomyocytes

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E4920-8. doi: 10.1073/pnas.1408964111. Epub 2014 Nov 3.

Abstract

In cardiomyocytes, calcium is known to control gene expression at the level of transcription, whereas its role in regulating alternative splicing has not been explored. Here we report that, in mouse primary or embryonic stem cell-derived cardiomyocytes, increased calcium levels induce robust and reversible skipping of several alternative exons from endogenously expressed genes. Interestingly, we demonstrate a calcium-mediated splicing regulatory mechanism that depends on changes of histone modifications. Specifically, the regulation occurs through changes in calcium-responsive kinase activities that lead to alterations in histone modifications and subsequent changes in the transcriptional elongation rate and exon skipping. We demonstrate that increased intracellular calcium levels lead to histone hyperacetylation along the body of the genes containing calcium-responsive alternative exons by disrupting the histone deacetylase-to-histone acetyltransferase balance in the nucleus. Consequently, the RNA polymerase II elongation rate increases significantly on those genes, resulting in skipping of the alternative exons. These studies reveal a mechanism by which calcium-level changes in cardiomyocytes impact on the output of gene expression through altering alternative pre-mRNA splicing patterns.

Keywords: alternative splicing; calcium; cardiomyocytes; histone hyperacetylation; transcriptional elongation rate.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylation
  • Alternative Splicing* / drug effects
  • Animals
  • Calcium Signaling / physiology*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / physiology
  • Exons
  • Gene Expression Regulation / physiology
  • Genes, Neurofibromatosis 1
  • Histone Deacetylases / physiology*
  • Histones / metabolism*
  • Mice
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Neurofibromin 1 / biosynthesis
  • Neurofibromin 1 / genetics
  • Potassium Chloride / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Protein Processing, Post-Translational / physiology*
  • RNA Polymerase II / metabolism
  • RNA, Messenger / biosynthesis
  • RNA, Small Interfering / pharmacology
  • Real-Time Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • TRPP Cation Channels / physiology
  • Transcription Elongation, Genetic

Substances

  • Histones
  • Neurofibromin 1
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • RNA, Small Interfering
  • TRPP Cation Channels
  • polycystic kidney disease 1 protein
  • Potassium Chloride
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • RNA Polymerase II
  • Histone Deacetylases